Abstract
The article highlights the stepwise strategy of long-term anti-ischemic drug therapy for patients with chronic coronary syndromes according to the 2019 European Society of Cardiology Recommendations, which should take into account certain features of the clinical course of the disease. The optimal approach should be adapted to the characteristics of each patient and the expected benefits from the prescribed therapy.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
